AFYREN Completes Biorefinery Takeover as YFI Price Diverges

Wednesday, Apr 1, 2026 12:13 am ET1min read
Aime RobotAime Summary

- AFYREN completes full acquisition of its AFYREN NEOXY biorefinery for €11.3MMMM--, gaining 100% control after a decade-long partnership with SPI.

- YFIYXT-- price dropped 23.86% over one year amid broader market shifts affecting industrial861072-- and energy sectors, contrasting with AFYREN's strategic expansion.

- Biorefinery upgrades (€45M CAPEX) aim to boost operational efficiency and meet rising demand, with phased improvements scheduled through 2027.

- Bpifrance's 7.5% stake and SPI's convertible bonds reinforce AFYREN's financial stability as it targets Group-level breakeven through biorefinery operations.

On APR 1 2026, YFI dropped by 0.2% within 24 hours to reach $2490, while it rose by 0.36% within 7 days, dropped by 0.2% within 1 month, and dropped by 23.86% within 1 year. The price movement reflects broader market sentiment and ongoing developments in industrial and energy sectors.

AFYREN has announced its full-year 2025 financial results and the full takeover of its AFYREN NEOXY biorefinery, a strategic move that is expected to influence the broader industrial and energy markets. The acquisition of the 49% stake held by co-shareholder SPI in the biorefinery concludes a decade-long partnership that led to the industrialization of the company’s technology. AFYREN now holds 100% control of the plant, following a cash consideration of €11.3 million.

The optimization of the plant is aimed at meeting growing commercial demand and includes significant capital expenditures. Two-thirds of the budgeted CAPEX will be used in 2026, with the remaining one-third allocated to 2027. The upgrades focus on strengthening the plant's infrastructure and improving production processes, including the use of high-resistance materials in purification stages and enhanced treatment and storage of finished products. These upgrades are being sequenced to minimize disruption to daily operations, with planned technical shutdowns scheduled for June and the final quarter of 2026.

The full takeover of the biorefinery is expected to enhance AFYREN’s operational efficiency and align governance between the parent company and the plant. With full control, AFYREN can now drive the plant’s ramp-up and consolidate revenue and EBITDA more effectively. The company’s post-investment objectives indicate that the plant’s full capacity will generate EBITDA sufficient to cover holding costs, including R&D, commercial, and support functions. This development is a milestone for the company, as it moves closer to achieving Group-level financial breakeven through the biorefinery alone.

AFYREN’s financial position remains robust, with Bpifrance continuing its support through the Large Venture fund, which holds a 7.5% stake in the company and a seat on the Board of Directors. Additionally, SPI retains a short-term presence through convertible bonds that are expected to be repaid by June 2027.

The announcement highlights AFYREN’s strategic focus on optimizing its industrial assets and building a sustainable growth model. With the full integration of the biorefinery, the company is well-positioned to strengthen its market presence and drive long-term value for stakeholders.

Delivering real-time analysis and insights on unexpected cryptocurrency price movements to keep traders ahead of the curve.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet